Drug Development Platform Companies for Next-Generation Ketamine & Psychedelic Therapeutics | |
In recent years, the landscape of mental health treatment has witnessed a paradigm shift, with the resurgence of interest in psychedelic and ketamine-based therapies. These groundbreaking treatments offer promising results for individuals suffering from a range of mental health disorders, including depression, anxiety, and post-traumatic stress disorder (PTSD). Key players in this therapeutic revolution are drug development platform companies, like Alto Neuroscience, Beckley Psytech, atai Life Sciences, Bright Minds Biosciences, and Delix Therapeutics. | |
Related Link: Click here to visit item owner's website (1 hit) | |
Target Prov.: Ontario Target City : Toronto Last Update : Nov 02, 2023 3:01 AM Number of Views: 30 | Item Owner : Bright Minds Biosciences Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |